Leptin stimulates ischemia-induced retinal neovascularization: Possible role of vascular endothelial growth factor expressed in retinal endothelial cells

Diabetes

Volumn 53, Issue 9, 2004, Pages 2443-2448

  Suganami, Eri ^a,b   Takagi, Hitoshi ^a   Ohashi, Hirokazu ^a   Suzuma, Kiyoshi ^a   Suzuma, Izumi ^a   Oh, Hideyasu ^a   Watanabe, Daisuke ^a   Ojima, Tomonari ^a   Suganami, Takayoshi ^b   Fujio, Yasushi ^c   Nakao, Kazuwa ^a   Ogawa, Yoshihiro ^b   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ISOPROTEIN; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; MUTANT PROTEIN; STAT3 PROTEIN; VASCULOTROPIN;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLINDNESS; CELL PROLIFERATION; DEVELOPED COUNTRY; DIABETIC RETINOPATHY; DOMINANT NEGATIVE MUTANT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HISTOGENESIS; HORMONE INHIBITION; MOUSE; MOUSE STRAIN; MUTANT; NEWBORN; NONHUMAN; OB OB MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ENDOTHELIUM CELL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; THERAPY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; DIABETIC RETINOPATHY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; ISCHEMIA; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXYGEN; PREGNANCY; RECEPTORS, CELL SURFACE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4344619563     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.9.2443     Document Type: Article

References (35)

1. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111, 1994
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
3. Engerman RL: Pathogenesis of diabetic retinopathy. Diabetes 38:1203-1206, 1989
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892:146-154, 1999
6. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763-770, 1998
7. Nakata M, Yada T, Soejima N, Maruyama I: Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48:426-429, 1999
8. Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130:671-680, 1999
9. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR : Biological action of leptin as an angiogenic factor. Science 281:1683-1686, 1998
10. Bouloumie A, Drexler HC, Lafontan M, Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059-1066, 1998
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
12. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K: Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829, 1999
13. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105:1243-1252, 2000
14. Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N, Ozdemir IC: Is leptin associated with diabetic retinopathy? Diabetes Care 23:371-376, 2000
15. Gariano RF, Nath AK, D'Amico DJ, Lee T, Sierra-Honigmann MR: Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 41:3576-3581, 2000
16. Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M, Aiello LP, King GL: Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci U S A 99:721-726, 2002
17. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP: Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37:2165-2176, 1996
18. King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036, 1985
19. Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y: 17 β-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 40:2122-2129, 1999
20. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15732-15739, 1999
21. Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES, Singer MJ, Walburger DK, Lokhov SG, Gall AA, Dempcy R, Reed MW, Meyer RB, Hedgpeth J: 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 28:655-661, 2000
22. Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, Osugi T, Izumi M, Oshima Y, Nakaoka Y, Hirota H, Kishimoto T, Yamauchi-Takihara K: Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 104:979-981, 2001
23. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 92:10457-10461, 1995
24. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584, 1994
25. Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM: Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 23:2027-2033, 2003
26. Werner N, Nickenig G: From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol 24:7-9, 2004
27. Seip M, Trygstad O: Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413:2-28, 1996
28. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008, 2002
29. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98:6390-6395, 2001
30. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47, 1997
31. Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y: Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 99:383-388, 2002
32. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111:1835-1842, 2003
33. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850, 1998
34. Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT: Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731-736, 1992
35. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736-741, 1996